Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | +0.54% | -8.35% | +594.60% |
May. 31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 203M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -62M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.01
x | P/E ratio 2025 * |
-3.8
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.73% |
1 day | +0.40% | ||
1 week | -8.35% | ||
Current month | -7.21% | ||
1 month | -0.27% | ||
3 months | -20.13% | ||
6 months | +521.67% | ||
Current year | +594.60% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 48 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | 53 | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 3.73 | +0.27% | 42 212 |
24-06-05 | 3.72 | +1.22% | 392,847 |
24-06-04 | 3.675 | -2.78% | 296,249 |
24-06-03 | 3.78 | -5.97% | 564,646 |
24-05-31 | 4.02 | -1.23% | 397,720 |
Delayed Quote Nasdaq, June 06, 2024 at 10:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+594.60% | 203M | |
+19.01% | 125B | |
+14.69% | 109B | |
-3.18% | 24.74B | |
+3.03% | 22.67B | |
-9.95% | 18.14B | |
-41.04% | 16.67B | |
-13.04% | 16.64B | |
+0.99% | 13.45B | |
+23.36% | 11.32B |
- Stock Market
- Equities
- ELEV Stock